Trintellix and Digoxin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trintellix (vortioxetine hydrobromide) and Digoxin (digoxin). Common drug interactions include abdominal discomfort among females and abdominal discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Trintellix and Digoxin. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Trintellix?

Trintellix has active ingredients of vortioxetine hydrobromide. It is often used in depression. eHealthMe is studying from 13,067 Trintellix users. Check the latest studies of Trintellix.

What is Digoxin?

Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 93,740 Digoxin users. Check the latest studies of Digoxin.



On Jul, 13, 2026

18 people who take Trintellix and Digoxin together, and have interactions are studied.

Trintellix and Digoxin drug interactions.

What are the common drug interactions of Trintellix and Digoxin, by gender? *:

female:

  1. Abdominal discomfort
  2. Dizziness
  3. Fall
  4. Flushing (the warm, red condition of human skin)
  5. Hypertension (high blood pressure)
  6. Migraine (headache)
  7. Nausea (feeling of having an urge to vomit)
  8. Pain
  9. Pruritus generalised (generalized itching)
  10. Pyrexia (fever)

male:

  1. Abdominal discomfort
  2. Back pain
  3. Myalgia (muscle pain)
  4. Nausea (feeling of having an urge to vomit)
  5. Pain in extremity
  6. Pain in jaw
  7. Palpitations (feelings or sensations that your heart is pounding or racing)
  8. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  9. Vomiting
  10. Diarrhoea

What are the common drug interactions of Trintellix and Digoxin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal discomfort
  2. Back pain
  3. Diarrhoea
  4. Fall
  5. Fatigue (feeling of tiredness)
  6. Fluid retention (an abnormal accumulation of fluid in the blood)
  7. Headache (pain in head)
  8. Hypervolaemia (abnormally increased volume of blood)
  9. Infusion site pain
  10. Loss of consciousness

30-39:

n/a

40-49:

  1. Asthenia (weakness)
  2. Cholecystitis infective (infection of gallbladder capable to infect other organs)
  3. Dizziness
  4. Fall
  5. Fatigue (feeling of tiredness)
  6. Femur fracture
  7. Haemoglobin decreased
  8. Injection site haemorrhage (bleeding from injection site)
  9. Injection site pain
  10. Malaise (a feeling of general discomfort or uneasiness)

50-59:

n/a

60+:

  1. Hypertension (high blood pressure)
  2. Pruritus generalised (generalized itching)
  3. Fall
  4. Flushing (the warm, red condition of human skin)
  5. Headache (pain in head)
  6. Hypoacusis (loss of hearing)
  7. Migraine (headache)
  8. Myalgia (muscle pain)
  9. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  10. Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 7 people, 38.89%
  2. Urinary Tract Infection: 1 person, 5.56%
  3. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 5.56%
  4. Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 5.56%
  5. Pyoderma Gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance): 1 person, 5.56%
  6. Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 1 person, 5.56%
  7. Pain: 1 person, 5.56%
  8. Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 1 person, 5.56%
  9. Neuralgia (pain in one or more nerves): 1 person, 5.56%
  10. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Trintellix and Digoxin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Trintellix and Digoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Trintellix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Digoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Trintellix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Digoxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on vortioxetine hydrobromide and digoxin (the active ingredients of Trintellix and Digoxin, respectively), and Trintellix and Digoxin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: